<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One hundred and fifty-four patients received allogeneic stem cell transplantations from HLA-matched siblings for various <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> from July 2001 to September 2006 </plain></SENT>
<SENT sid="1" pm="."><plain>Indications for transplantation included <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (n=66), <z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">beta-thalassemia major</z:e> (n=40), <z:mp ids='MP_0005481'>CML</z:mp> (n=33), <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (n=8), and miscellaneous disorders (n=7) </plain></SENT>
<SENT sid="2" pm="."><plain>One hundred and twenty patients were males and 34 were females </plain></SENT>
<SENT sid="3" pm="."><plain>Median patient age was 14 years (range, 1(1/4)-54 years) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients achieved successful engraftment </plain></SENT>
<SENT sid="5" pm="."><plain>Median time to engraftment (ANC&gt;0.5x10(9)/L) was 14 days </plain></SENT>
<SENT sid="6" pm="."><plain>Posttransplant complications encountered in our patients included <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft versus host disease</z:e> (GvHD) (grade II-IV) 28.5%, <z:hpo ids='HP_0011010'>chronic</z:hpo> GvHD 15.5%, <z:e sem="disease" ids="C0085692" disease_type="Disease or Syndrome" abbrv="">hemorrhagic cystitis</z:e> 9.7%, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e> liver 5.1%, <z:hpo ids='HP_0001919'>acute renal failure</z:hpo> 3.2%, <z:mp ids='MP_0001794'>bacterial</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> 51.2%, <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e> 15.0%, cytomegalovirus (CMV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> 4%, <z:e sem="disease" ids="C0019360" disease_type="Disease or Syndrome" abbrv="ZONA">herpes zoster</z:e> 4%, <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e> 2.6%, Pneumocystis jirovicii <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> 0.6%, <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> 0.6% patients, graft rejection 5.2% patients, and relapse in 4% patients </plain></SENT>
<SENT sid="7" pm="."><plain>Certain unexpected and rare posttransplant complications were also observed in our patients </plain></SENT>
<SENT sid="8" pm="."><plain>These included Hickman catheter embolization, Guillain-Barr√© (GB) syndrome, <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo>, hemorrhagic <z:hpo ids='HP_0001701'>pericarditis</z:hpo> with clots leading to <z:e sem="disease" ids="C0007177" disease_type="Disease or Syndrome" abbrv="">cardiac tamponade</z:e>, idiopathic <z:hpo ids='HP_0001901'>polycythemia</z:hpo>, <z:e sem="disease" ids="C0011311" disease_type="Disease or Syndrome" abbrv="">dengue</z:e> <z:hpo ids='HP_0001945'>fever</z:hpo>, and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi>-induced neurotoxicity </plain></SENT>
<SENT sid="9" pm="."><plain>Mortality was observed in 27.2% patients </plain></SENT>
<SENT sid="10" pm="."><plain>Major causes of mortality were GvHD, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VOD</z:e>, disease relapse, <z:hpo ids='HP_0002170'>intracranial hemorrhage</z:hpo>, <z:hpo ids='HP_0001919'>acute renal failure</z:hpo>, pseudomonas <z:mpath ids='MPATH_681'>septicemia</z:mpath>, <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e>, <z:e sem="disease" ids="C0004032" disease_type="Disease or Syndrome" abbrv="">disseminated aspergillosis</z:e>, and <z:e sem="disease" ids="C0010823" disease_type="Disease or Syndrome" abbrv="">CMV infection</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>At 5 years, overall survival (OS) and disease-free survival (DFS) rates were 72.5% and 70.7%, respectively </plain></SENT>
</text></document>